Travere Therapeutics Inc (NASDAQ:TVTX)

18.98
Delayed Data
As of 4:00pm ET
 -0.51 / -2.62%
Today’s Change
18.92
Today|||52-Week Range
31.65
-38.85%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Dube Eric /glaxosmithkline/
Chief Executive Officer
Sale1/05/202210,361$29.84$309.2K-33.46%
Clague Laura M
Chief Financial Officer
Sale1/11/20227,500$27.40$205.5K-29.56%
Dube Eric /glaxosmithkline/
Chief Executive Officer
Sale1/24/20227,873$24.98$196.7K-24.84%
Dube Eric /glaxosmithkline/
Chief Executive Officer
Sale1/04/20224,832$30.43$147.0K-36.10%
Reed Elizabeth E
Secretary, Senior Vice President & General Counsel
Sale1/11/20225,000$27.40$137.0K-29.56%
Dube Eric /glaxosmithkline/
Chief Executive Officer
Sale2/10/20224,832$27.84$134.5K-28.92%
Dube Eric /glaxosmithkline/
Chief Executive Officer
Sale1/31/20224,813$27.40$131.9K-29.13%
Rote William E
Senior Vice President-Research & Development
Sale1/11/20222,500$27.40$68.5K-29.56%
Dube Eric /glaxosmithkline/
Chief Executive Officer
Sale1/05/20222,139$30.48$65.2K-33.46%
Reed Elizabeth E
Secretary, Senior Vice President & General Counsel
Sale1/24/20222,250$24.98$56.2K-24.84%
Page of 4